ArticleBone marrow transplantation2024

Incidence, risk factors and therapy response of acute graft-versus-host disease after myeloablative hematopoietic stem cell transplantation with posttransplant cyclophosphamide.

P Asensi Cantó et al.PubMed ↗Publisher ↗

No numbers read from the abstract.